Trials / Completed
CompletedNCT03211403
Multiple Doses Study of SHR4640 in Male Subjects With High Serum Uric Acid Level
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of SHR4640 in Male Subjects With High Serum Uric Acid Level
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Atridia Pty Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-Center, randomized, double-Blind, placebo-controlled, multiple ascending-dose Phase I trail.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR4640 | SHR4640 or placebo once daily for a week |
Timeline
- Start date
- 2017-07-04
- Primary completion
- 2018-02-15
- Completion
- 2018-02-15
- First posted
- 2017-07-07
- Last updated
- 2018-03-21
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT03211403. Inclusion in this directory is not an endorsement.